Diabetes Mellitus Tipe 2: Prevalensi, Etiologi, dan Penatalaksanaannya
DOI:
https://doi.org/10.55642/phasij.v5i01.981Keywords:
diabetes mellitus tipe 2, glukosa darah, obatAbstract
Non-Communicable Diseases (NCDs), such as Diabetes Mellitus (DM), are chronic conditions not transmitted between individuals, often caused by unhealthy lifestyles, poor environmental factors, or genetics. With 536.6 million cases globally, DM is a significant health concern, particularly in Indonesia, due to its serious complications if left unmanaged. This literature review examines scientific articles, textbooks, and official publications to explore the prevention and treatment of DM, particularly Type 2 Diabetes Mellitus (T2DM). T2DM, also known as Non-Insulin Dependent Diabetes Mellitus (NIDDM), results from impaired insulin secretion by pancreatic β-cells and reduced tissue sensitivity to insulin. The condition poses a significant risk for complications such as cardiovascular disease, nephropathy, and retinopathy. Despite its prevalence, diagnosis often goes unnoticed due to mild or absent symptoms and relies on blood glucose and HbA1c levels. Effective management includes lifestyle modifications like increased physical activity and healthy dietary patterns, along with tailored pharmacological treatments. New drug classes, including SGLT2 inhibitors and GLP-1 receptor agonists, offer additional benefits, such as weight loss and cardiovascular protection, highlighting advancements in treatment options.
References
Kementerian Kesehatan Republik Indonesia, Peraturan Menteri Kesehatan Republik Indonesia Nomor 71 Tahun 2015 tentang Penanggulangan Penyakit Tidak Menular. Indonesia: Kementerian Kesehatan RI, 2015.
Kementerian Kesehatan Republik Indonesia, Buku Informasi Cegah dan Kendalikan Penyakit Tidak Menular (PTM). Jakarta: Kementerian Kesehatan RI, 2021.
World Health Organization, “The Global Diabetes Compact – Progress in Supporting its Workstreams, Technical Reports,” Geneva, 2024.
A. Belayneh et al., “Investigation of Non-communicable Diseases Prevalence, Patterns, and Patient Outcomes in Hospitalized Populations: A Prospective Observational Study in Three Tertiary Hospitals,” J Health Popul Nutr, vol. 43, no. 1, p. 128, Aug. 2024, doi: 10.1186/s41043-024-00599-z.
International Diabetes Federation, IDF Diabetes Atlas 2021, 10th ed. Geneva: WHO, 2021.
C. S. Zeind, M. G. Carvalho, J. W. M. Cheng, K. Zaiken, and T. LaPointe, Applied Therapeutics the Clinical Use of Drugs. Mexico City: Wolters Kluwer, 2024.
Badan Kebijakan Pembangunan Kesehatan, “Survei Kesehatan Indonesia (SKI),” Jakarta, 2023.
J. Harreiter and M. Roden, “Diabetes Mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2023),” Wien Klin Wochenschr, vol. 135, no. S1, pp. 7–17, Jan. 2023, doi: 10.1007/s00508-022-02122-y.
S. Carbone, M. G. Del Buono, C. Ozemek, and C. J. Lavie, “Obesity, Risk of Diabetes and Role of Physical Activity, Exercise Training and Cardiorespiratory Fitness,” Prog Cardiovasc Dis, vol. 62, no. 4, pp. 327–333, Jul. 2019, doi: 10.1016/j.pcad.2019.08.004.
A. Kautzky-Willer, J. Harreiter, and G. Pacini, “Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus,” Endocr Rev, vol. 37, no. 3, pp. 278–316, Jun. 2016, doi: 10.1210/er.2015-1137.
U. Galicia-Garcia et al., “Pathophysiology of Type 2 Diabetes Mellitus,” Int J Mol Sci, vol. 21, no. 17, p. 6275, Aug. 2020, doi: 10.3390/ijms21176275.
U. K. Sharma, M. Pujani, and J. Anuradha, “Type-II-Diabetes Mellitus- Etiology, Epidemiology, Risk Factors and Diagnosis and Insight into Demography (Urban Versus Rural),” Int J Health Sci Res, vol. 14, no. 1, pp. 284–290, 2024.
H. Guo, H. Wu, and Z. Li, “Review, The Pathogenesis of Diabetes,” Int J Mol Sci, vol. 24, pp. 1–23, 2023.
M. Z. Banday, A. S. Sameer, and S. Nissar, “Pathophysiology of Diabetes: An Overview,” Avicenna J Med, vol. 10, no. 04, pp. 174–188, Oct. 2020, doi: 10.4103/ajm.ajm_53_20.
A. Kautzky-Willer, M. Leutner, and J. Harreiter, “Sex Differences in Type 2 Diabetes,” Diabetelogia, no. 66, pp. 986–1002, 2023.
Y. Wu, Y. Ding, Y. Tanaka, and W. Zhang, “Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention,” Int J Med Sci, vol. 11, no. 11, pp. 1185–1200, 2014, doi: 10.7150/ijms.10001.
S. S. Schwartz, S. Epstein, B. E. Corkey, S. F. A. Grant, J. R. Gavin, and R. B. Aguilar, “The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema,” Diabetes Care, vol. 39, no. 2, pp. 179–186, Feb. 2016, doi: 10.2337/dc15-1585.
International Diabetes Federation, “Hearts-D: Diagnosis and Management of Type 2 Diabetes,” 2020, WHO, Geneva.
World Health Organization, “Classification of Diabetes Mellitus,” 2019, WHO, Geneva.
M. Cicek, J. Buckley, J. Pearson-Stuttard, and E. W. Gregg, “Characterizing Multimorbidity from Type 2 Diabetes,” Endocrinol Metab Clin North Am, vol. 50, no. 3, pp. 531–558, Sep. 2021, doi: 10.1016/j.ecl.2021.05.012.
F. Cannata, G. Vadalà, F. Russo, R. Papalia, N. Napoli, and P. Pozzilli, “Beneficial Effects of Physical Activity in Diabetic Patients,” J Funct Morphol Kinesiol, vol. 5, no. 3, p. 70, Sep. 2020, doi: 10.3390/jfmk5030070.
A. D. Putri, Netti, Suhaimi, and N. Yanti, “Teknik Relaksasi Otot Progresif pada Pasien DM Tipe 2 dengan Ketidakstabilan Kadar Glukosa Darah: Case Report,” JHCN: Journal of Health and Cardiovascular Nursing, vol. 3, no. 2, pp. 109–117, 2023.
R. Simatupang, Pedoman Diet Penderita Diabetes Mellitus. Banten: Yayasan Pendidikan dan Sosial Indonesia Maju (YPSIM) Indonesia, 2020.
C. M. Khoo, “Diabetes Mellitus Treatment,” International Encyclopedia of Public Health 2nd Edition, pp. 228–293, 2017.
E. Decroli, Diabetes Melitus Tipe 2. Padang: Pusat Penerbitan Bagian Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Andalas, 2019.
M. J. Davies et al., “Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD),” Diabetes Care, vol. 45, no. 11, pp. 2753–2786, Nov. 2022, doi: 10.2337/dci22-0034.
J. T. DiPiro, G. C. Yee, L. M. Posey, S. T. Haines, T. D. Nolin, and V. Ellingrod, Pharmacotherapy A Pathophysiologic Approach , 12th ed. New York: McGraw Hill, 2023.
D. C. Yohanes, “Penghambat Sodium-Glucose Cotransporter-2,” Acta Pharmaciae Indonesia : Acta Pharm Indo, vol. 8, no. 1, p. 26, Mar. 2020, doi: 10.20884/1.api.2020.8.1.2450.
P. M. S. D. Pathni, “). Tren Terapi Diabetes dengan GLP-1 Receptor Agonist,” CDK-263, vol. 45, no. 4, 2018.
J. K. Aronson, Ed., “Biguanides,” in Meyler’s Side Effects of Drugs, 16th ed., New York: Elsevier, 2016.
D. Sola et al., “State of the Art Paper Sulfonylureas and Their Use in Clinical Practice,” Archives of Medical Science, vol. 4, pp. 840–848, 2015, doi: 10.5114/aoms.2015.53304.
X. Li and Z. Q. Liu, Pharmacogenetic Factors that Affect Drug Metabolism and Efficacy in Type 2 Diabetes Mellitus, dalam Drug Metabolism in Diseases. New York: Elsevier, 2017.
B. Omar and B. Ahrén, “Pleiotropic Mechanisms for the Glucose-Lowering Action of DPP-4 Inhibitors,” Diabetes, vol. 63, no. 7, pp. 2196–2202, Jul. 2014, doi: 10.2337/db14-0052.
Perkumpulan Endokrinologi Indonesia, Pedoman Pengelolaan dan Pencegahan Diabetes Mellitus Tipe 2 Dewasa di Indonesia. Jakarta: PB PERKENI, 2019.
F. Cao, K. Wu, Y.-Z. Zhu, and Z.-W. Bao, “Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging,” Front Endocrinol (Lausanne), vol. 12, Aug. 2021, doi: 10.3389/fendo.2021.731273.
S. Basak, A. Murmu, B. W. Matore, P. P. Roy, and J. Singh, “Thiazolidinedione an Auspicious Scaffold as PPAR-γ Agonist: Its Possible Mechanism to Manoeuvre Against Insulin Resistant Diabetes Mellitus,” European Journal of Medicinal Chemistry Reports, vol. 11, p. 100160, Aug. 2024, doi: 10.1016/j.ejmcr.2024.100160.
V. L. Maheshwari and R. H. Patil, Eds., Natural Products as Enzyme Inhibitors, An Industrial Perspective. New York: Elsevier, 2022.
W. Lv, X. Wang, Q. Xu, and W. Lu, “Mechanisms and Characteristics of Sulfonylureas and Glinides,” Curr Top Med Chem, vol. 20, no. 1, pp. 37–56, Jan. 2020, doi: 10.2174/1568026620666191224141617.
